Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Medical Oncology (Northwood, London, England)|July 26, 2011
The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapyYanqin Yang, Jize Xuan, Zhiqiang Yang, et al.
Cancers|January 8, 2023
Strategies to Optimize Treatment for Locally Advanced Rectal CancerXiaoyu Hu, Zhuang Xue, Kewen He, et al.
Therapeutic Advances in Gastroenterology|February 17, 2017
Minimum absolute lymphocyte counts during radiation are associated with a worse prognosis in patients with unresectable hepatocellular carcinomaQianqian Zhao, Xiaoqing Xu, Jinbo Yue, et al.
Cancer Letters|January 26, 2024
PARP inhibitor plus radiotherapy reshape the immune suppressive microenvironment and potentiate the efficacy of immune checkpoint inhibitors in tumors with IDH1 mutationXiaoyu Hu, Mengyu Zhao, Menglin Bai, et al.
Frontiers in Oncology|May 9, 2022
Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal CancerChao Liu, Peiliang Wang, Yi Sun, et al.
Biomarker Research|September 18, 2024
Tumor endothelium-derived PODXL correlates with immunosuppressive microenvironment and poor prognosis in cervical cancer patients receiving radiotherapy or chemoradiotherapyRui Huang, Fuhao Wang, Wenxue Zou, et al.
Frontiers in Immunology|May 28, 2026
Sintilimab plus fruquintinib with or without radiotherapy for third-line treatment of colorectal cancer with liver metastases: study protocol for a randomized controlled, multicenter phase II trialZhenyu Ma, Kunli Zhu, Fang Shi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2023
[18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinomaZiyuan Zhu, Kai Cheng, Zhang Yun, et al.
Practical Radiation Oncology|March 20, 2025
Patterns of Recurrence After D2 Radical Surgery for Gastric Cancer: Implications for Postoperative Radiation TherapyWenheng Jiang, Haohua Wang, Xiang Zhang, et al.
BMJ Open|June 9, 2026
Continuation of first-line therapy with radiotherapy for oligoprogression versus early switch to second-line therapy in oligoprogressive hepatocellular carcinoma (CROSS): study protocol of a multicentre, randomised, controlled, open-label, phase III trialHaohua Wang, Fang Shi, Xiang Zhang, et al.
Pageof 10